BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17696576)

  • 21. [Retrospective analysis of 24 recurrent glioblastoma after chemoradiation and treated with nitrosoureas or irinotecan and bevacizumab].
    Vauleon E; Mesbah H; Gedouin D; Lecouillard I; Louvel G; Hamlat A; Riffaud L; Carsin B; Quillien V; Audrain O; Lesimple T
    Bull Cancer; 2012 Feb; 99(2):121-6. PubMed ID: 22257744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current chemotherapy for glioblastoma.
    Parney IF; Chang SM
    Cancer J; 2003; 9(3):149-56. PubMed ID: 12952300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.
    Stupp R; Hegi ME; Mason WP; van den Bent MJ; Taphoorn MJ; Janzer RC; Ludwin SK; Allgeier A; Fisher B; Belanger K; Hau P; Brandes AA; Gijtenbeek J; Marosi C; Vecht CJ; Mokhtari K; Wesseling P; Villa S; Eisenhauer E; Gorlia T; Weller M; Lacombe D; Cairncross JG; Mirimanoff RO; ;
    Lancet Oncol; 2009 May; 10(5):459-66. PubMed ID: 19269895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A meta-analysis of bevacizumab alone and in combination with irinotecan in the treatment of patients with recurrent glioblastoma multiforme.
    Zhang G; Huang S; Wang Z
    J Clin Neurosci; 2012 Dec; 19(12):1636-40. PubMed ID: 23047061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Temozolomide and thalidomide in the treatment of glioblastoma multiforme.
    Riva M; Imbesi F; Beghi E; Galli C; Citterio A; Trapani P; Sterzi R; Collice M
    Anticancer Res; 2007; 27(2):1067-71. PubMed ID: 17465245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patterns of care and survival of glioblastoma patients: a comparative study between 2004 and 2008 in Lyon, France.
    Badaoui N; Meyronet D; Cartalat-Carel S; Guyotat J; Jouanneau E; d'Hombres A; Sunyach MP; Jouvet A; Louis-Tisserand G; Archinet A; Frappaz D; Bauchet L; Honnorat J; Ducray F
    Rev Neurol (Paris); 2014 Mar; 170(3):222-7. PubMed ID: 24582303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neoadjuvant bevacizumab and irinotecan versus bevacizumab and temozolomide followed by concomitant chemoradiotherapy in newly diagnosed glioblastoma multiforme: A randomized phase II study.
    Hofland KF; Hansen S; Sorensen M; Engelholm S; Schultz HP; Muhic A; Grunnet K; Ask A; Costa JC; Kristiansen C; Thomsen C; Poulsen HS; Lassen U
    Acta Oncol; 2014 Jul; 53(7):939-44. PubMed ID: 24456504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical outcome of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastaomas: single-center experience.
    Jeon HJ; Kong DS; Park KB; Lee JI; Park K; Kim JH; Kim ST; Lim DH; Kim WS; Nam DH
    Clin Neurol Neurosurg; 2009 Oct; 111(8):679-82. PubMed ID: 19640635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.
    Lanzetta G; Campanella C; Rozzi A; Nappa M; Costa A; Fedele F; Innocenzi G; Gagliardi FM; Salvati M; Minniti G; Frati A; Frati L; Vecchione A
    Anticancer Res; 2003; 23(6D):5159-64. PubMed ID: 14981983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. State-of-the-art treatment of high-grade brain tumors.
    Brandes AA
    Semin Oncol; 2003 Dec; 30(6 Suppl 19):4-9. PubMed ID: 14765377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concomitant and adjuvant temozolomide of newly diagnosed glioblastoma in elderly patients.
    Behm T; Horowski A; Schneider S; Bock HC; Mielke D; Rohde V; Stockhammer F
    Clin Neurol Neurosurg; 2013 Oct; 115(10):2142-6. PubMed ID: 23993314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Initial experience involving treatment and retreatment with carmustine wafers in combination with oral temozolomide: long-term survival in a child with relapsed glioblastoma multiforme.
    Márquez-Rivas J; Ramirez G; Ollero-Ortiz A; Giménez-Pando J; Emmerich J; Quiroga-Cantero E; Rivas E; Gómez-González E
    J Pediatr Hematol Oncol; 2010 Jul; 32(5):e202-6. PubMed ID: 20523247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concurrent radiotherapy and temozolomide followed by temozolomide and sorafenib in the first-line treatment of patients with glioblastoma multiforme.
    Hainsworth JD; Ervin T; Friedman E; Priego V; Murphy PB; Clark BL; Lamar RE
    Cancer; 2010 Aug; 116(15):3663-9. PubMed ID: 20564147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advantages and Disadvantages of Combined Chemotherapy with Carmustine Wafer and Bevacizumab in Patients with Newly Diagnosed Glioblastoma: A Single-Institutional Experience.
    Akiyama Y; Kimura Y; Enatsu R; Mikami T; Wanibuchi M; Mikuni N
    World Neurosurg; 2018 May; 113():e508-e514. PubMed ID: 29476996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy of temozolomide combined with levetiracetam for glioblastoma (GBM) after surgery: a study protocol for a double-blinded and randomized controlled trial.
    Sun M; Huang N; Tao Y; Wen R; Zhao G; Zhang X; Xie Z; Cheng Y; Mao J; Liu G
    Trials; 2022 Mar; 23(1):234. PubMed ID: 35346332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Survival Analysis with Identification of Prognostic Factors in a Series of 110 Patients with Newly Diagnosed Glioblastoma Before and After Introduction of the Stupp Regimen: A Single-Center Observational Study.
    Illic R; Somma T; Savic D; Frio F; Milicevic M; Solari D; Nikitovic M; Lavrnic S; Raicevic S; Milosevic S; Cavallo LM; Cappabianca P; Grujicic D
    World Neurosurg; 2017 Aug; 104():581-588. PubMed ID: 28522381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of temozolomide treatment in patients with high-grade glioma.
    Oshiro S; Tsugu H; Komatsu F; Ohmura T; Ohta M; Sakamoto S; Fukushima T; Inoue T
    Anticancer Res; 2009 Mar; 29(3):911-7. PubMed ID: 19414327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Temozolomide in second-line treatment after prior nitrosurea-based chemotherapy in glioblastoma multiforme: experience from a Portuguese institution.
    Teixeira MM; Garcia I; Portela I; Cernuda M; Oliveira C; Albano J; Lima L
    Int J Clin Pharmacol Res; 2002; 22(1):19-22. PubMed ID: 12395915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postoperative treatment of glioblastoma multiforme with radiation therapy plus concomitant and adjuvant temozolomide : A mono-institutional experience of 215 patients.
    Julka PK; Sharma DN; Mallick S; Gandhi AK; Joshi N; Rath GK
    J Cancer Res Ther; 2013; 9(3):381-6. PubMed ID: 24125970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [What type of adjuvant chemotherapy should be proposed for the initial treatment of glioblastoma?].
    Ducray F; Honnorat J
    Presse Med; 2007 Sep; 36(9 Pt 2):1249-54. PubMed ID: 17350791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.